We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Comprehensive Biorepository Includes Genomic and Proteomic Tissue Products

By LabMedica International staff writers
Posted on 24 Jun 2010
Print article
A comprehensive range of certified tissue products for genomic and proteomic research is being offered including genomic DNA, complementary DNA (cDNA), RNA, and protein.

All tissue products are produced using rigorous standard operating procedures, and through ethical procurement, to ensure only the highest quality materials are available in the Amsbio Biorepository (Abingdon, UK). Samples have been isolated from hundreds of different source tissues including human normal and diseased tissues, and a variety of genetic model organisms including mouse, rat, primate, and plant species. These specimens are provided ready-to-use enabling the immediate study of molecules of interest in many different tissues and eliminating the need for time consuming in-house sample preparation.

The range of available samples includes individual genomic DNA preparations, together with 96-well genomic DNA (gDNA) plates from tumor and normal tissue for Epigenetics studies. Tissue-specific polymerase chain reaction (PCR)-ready first strand cDNAs, universal cDNA and cDNA panels are available for gene expression studies. Amsbio total and universal RNA products are isolated with microRNAs and are available with RIN (RNA integrity number) values, upon request, for microarray studies. Total protein products from normal and disease state tissues add further research possibilities with whole tissue lysates and sub cellular fractions from the nucleus, cytoplasm, cell membrane, and cytoskeleton.

These tissue products are produced from Amsbio's extensive bank of clinical and veterinary specimens that form a unique range of tissue samples in formalin-fixed paraffin embedded (FFPE) or snap-frozen formats including frozen tissue microarrays.

AMS Biotechnology (Amsbio) is a leading international provider of products and custom services for life sciences research. The Amsbio range includes over 23,000 polyclonal and monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, as well as tissue DNA, RNA, protein, and microarray products.

Related Links:
Amsbio Biorepository



Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
New
Cortisol Rapid Test
Finecare Cortisol Rapid Quantitative Test

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more

Pathology

view channel
Image: The artificial intelligence models can personalize immune therapies in oncology patients (Photo courtesy of 123RF)

AI Tool Identifies Novel Genetic Signatures to Personalize Cancer Therapies

Lung cancer and bladder cancer are among the most commonly diagnosed cancers globally. Researchers have now developed artificial intelligence (AI) models designed to personalize immune therapies for oncology... Read more

Technology

view channel
Image: Schematic diagram of nanomaterial-based anti-epileptic drug concentration diagnostic technology (Photo courtesy of KRISS)

Nanomaterial-Based Diagnostic Technology Accurately Monitors Drug Therapy in Epilepsy Patients

Many patients with epilepsy take anti-epileptic drugs to control frequent seizures in their daily lives. To optimize treatment and avoid side effects from overdosing, it is crucial for patients to regularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.